Genesis Healthcare Inc. Financials

Market Capitalization $18.49 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	28.94
Forward PE	12.17
Price to Sales TTM	$4.70
Price to Book MRQ	$8.11
Enterprise to Revenue	6.49
Enterprise to EBITDA	13.60

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-28
Most Recent Quarter	2025-03-31
Profit Margin	16.34%
Operating Margin	44.26%
Return on Assets TTM	6.74%
Return on Equity TTM	29.17%

Income Statement

Revenue TTM	$3,935,000,064
Revenue per Share TTM	$6.38
Quarterly Revenue Growth	4.80%
Gross Profit TTM	$3,159,000,064
EBITDA	$2,064,000,000
Net Income to Common TTM	$643,000,000
Diluted EPS TTM	$1.03
Quarterly Earnings Growth YoY	8.40%

Balance Sheet

Total Cash MRQ	$1,006,000,000
Total Cash per Share MRQ	$1.62
Total Debt MRQ	$
Total Debt to Equity MRQ	366.46
Current Ratio MRQ	0.51
Book Value per Share MRQ	$3.68

Cash Flow

Operating Cash Flow TTM	$1,220,999,936
Levered Free Cash Flow TTM	$1,312,499,968

GEN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	617,000,000
Float Shares	525,712,902
Avg 10 Volume	5,094,556
Avg 30 Volume	None
Shares Short	17,646,710
Short Ratio	3.36
Short % of Shares	3.69%
% Held by Insiders	9.49%
% Held by Institutions	101.34%

Stock Price Summary

Beta	1.01
Fifty Two Week Low	$22.74
Fifty Two Week High	$31.72
Fifty Two Week Change	19.19%
Day 50 MA	$28.03
Day 200 MA	$27.79

Dividends and Splits

Forward Annual Dividend Rate	$0.50
Forward Annual Dividend Yield	1.64%
Trailing Annual Dividend Rate	$0.50
Trailing Annual Dividend Yield	1.64%
Payout Ratio	48.54%
Dividend Date	2025-06-11
Ex Dividend Date	2025-05-19
Last Split Factor
Last Split Date	2004-12-01